A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases

炎症体 化学 炎症 免疫学 生物
作者
Callum AH Docherty,Anuruddika J Fernando,Sarah Rosli,Maggie Lam,Roland E. Dolle,Manuel A. Navia,Ronald Farquhar,Danny La France,Michelle D. Tate,Christopher K. Murphy,Adriano G. Rossi,Ashley Mansell
出处
期刊:Clinical & translational immunology [Wiley]
卷期号:12 (6): e1455-e1455 被引量:37
标识
DOI:10.1002/cti2.1455
摘要

Abstract Objectives Inflammasomes induce maturation of the inflammatory cytokines IL‐1β and IL‐18, whose activity is associated with the pathophysiology of a wide range of infectious and inflammatory diseases. As validated therapeutic targets for the treatment of acute and chronic inflammatory diseases, there has been intense interest in developing small‐molecule inhibitors to target inflammasome activity and reduce disease‐associated inflammatory burden. Methods We examined the therapeutic potential of a novel small‐molecule inhibitor, and associated derivatives, termed ADS032 to target and reduce inflammasome‐mediated inflammation in vivo . In vitro , we characterised ADS032 function, target engagement and specificity. Results We describe ADS032 as the first dual NLRP1 and NLRP3 inhibitor. ADS032 is a rapid, reversible and stable inflammasome inhibitor that directly binds both NLRP1 and NLRP3, reducing secretion and maturation of IL‐1β in human‐derived macrophages and bronchial epithelial cells in response to the activation of NLPR1 and NLRP3. ADS032 also reduced NLRP3‐induced ASC speck formation, indicative of targeting inflammasome formation. In vivo , ADS032 reduced IL‐1β and TNF‐α levels in the serum of mice challenged i.p. with LPS and reduced pulmonary inflammation in an acute model of lung silicosis. Critically, ADS032 protected mice from lethal influenza A virus challenge, displayed increased survival and reduced pulmonary inflammation. Conclusion ADS032 is the first described dual inflammasome inhibitor and a potential therapeutic to treat both NLRP1‐ and NLRP3‐associated inflammatory diseases and also constitutes a novel tool that allows examination of the role of NLRP1 in human disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
主任完成签到 ,获得积分10
刚刚
芥菜种子完成签到 ,获得积分10
1秒前
张美超发布了新的文献求助10
1秒前
lan完成签到,获得积分10
1秒前
郑睿涛完成签到,获得积分10
2秒前
ojoijn发布了新的文献求助10
2秒前
404发布了新的文献求助10
2秒前
qizhang完成签到,获得积分10
2秒前
CodeCraft的应助被游标卡尺采纳,获得10
2秒前
姜雨杭发布了新的文献求助10
2秒前
长生发布了新的文献求助10
3秒前
3秒前
3秒前
迪迪子完成签到,获得积分10
3秒前
甜美冰香发布了新的文献求助10
3秒前
4秒前
4秒前
江北小赵发布了新的文献求助10
4秒前
zhangyaoyang发布了新的文献求助10
4秒前
三笠发布了新的文献求助10
5秒前
5秒前
n11发布了新的文献求助10
5秒前
江城撒花的果蔬完成签到,获得积分10
5秒前
6秒前
ddd完成签到,获得积分10
6秒前
会撒娇的梦竹完成签到 ,获得积分10
6秒前
7秒前
蓝天发布了新的文献求助10
7秒前
11发布了新的文献求助10
7秒前
甜瓜甜完成签到,获得积分10
7秒前
小鱼完成签到,获得积分10
7秒前
8秒前
serena发布了新的文献求助10
8秒前
denisewang发布了新的文献求助10
8秒前
桐桐的应助被听话的绿柳采纳,获得10
9秒前
CodeCraft的应助被坚强孤容采纳,获得10
9秒前
111发布了新的文献求助10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183046
求助须知:如何正确求助?哪些是违规求助? 9572370
关于积分的说明 21824411
捐赠科研通 7779694
什么是DOI,文献DOI怎么找? 3433792
关于科研通互助平台的介绍 2558024
邀请新用户注册赠送积分活动 2479971